Who owns the MABCALIN trademark?

The MABCALIN trademark is owned by Pieris Pharmaceuticals GmbH.

What is the serial number for MABCALIN?

The USPTO serial number for MABCALIN is 79361821.

What is the registration number for MABCALIN?

MABCALIN is registered under USPTO registration number 7459076.

MAB

USPTO Trademark Record

REGISTERED

MABCALIN

Q: What class is the MABCALIN trademark registered in?

The MABCALIN trademark is registered in Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79361821·Reg 7459076·Filed Dec 19, 2022

Owner Pieris Pharmaceuticals GmbH

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides; adhesives for use in industry; compost, manures, fertilizers; biological preparations for use in industry and science.; Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MABCALIN (Serial No. 79361821), Registration No. 7459076, is a registered US trademark filed on Dec 19, 2022 by Pieris Pharmaceuticals GmbH. This trademark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: July 30, 2030

Mark Intelligence

MABCALIN (Reg. #7459076) is a registered US trademark that has been protecting its owner, Pieris Pharmaceuticals GmbH, since 2022. The mark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocesse.... The mark faced 4 opposition proceedings during prosecution.

FILED

Dec 19, 2022

SERIAL

79361821

REG#

7459076

REGISTERED

Jul 30, 2024

Owner

Applicant

Pieris Pharmaceuticals GmbH

Entity

GmbH (German)

Address

Zeppelinstrasse 3, 85399 Hallbergmoos

Country

Attorney

NameMichael J. Leonard

Law firm

Michael J. Leonard Fox Rothschild LLP

Docket

114381.00010

Address

997 Lenox Drive, Bldg. 3, Lawrenceville, NJ 08648-2311, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 19, 2022

Serial Number79361821

Registration No.7459076

Registration DateJul 30, 2024

Status DateJul 30, 2024

Published for OppositionMay 14, 2024

Mark TypeStandard characters

Attorney Docket114381.00010

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 001Chemicals for industrial, scientific & agricultural use

US codes: 001, 005, 006, 010, 026, 046

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 08, 2025

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jan 22, 2025

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jan 22, 2025

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 30, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Aug 03, 2024

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

REGISTERED-PRINCIPAL REGISTER

Jul 30, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 30, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jul 12, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jul 12, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

PUBLISHED FOR OPPOSITION

May 14, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 14, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 24, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 08, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 08, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 08, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 08, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

REFUSAL PROCESSED BY IB

Nov 07, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Oct 16, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 16, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 01, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 30, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 20, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Feb 10, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 06, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 03, 2023

SN ASSIGNED FOR SECT 66A APPL FROM IB

MABCALIN

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Pieris Pharmaceuticals GmbH

Other Marks by Michael J. Leonard

Resources

Company